Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema (BLUE SKY)
OBservationaL stUdy to Evaluate Fluid reSolution and Effectiveness in Patients Receiving Beovu (Brolucizumab) Under KeY Treatment Schemes in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema
Sponsor: Novartis Pharmaceuticals
Listed as NCT04543331, this observational or N/A phase trial focuses on Diabetic Macular Edema (DME) and Neovascular Age-related Macular Degeneration (nAMD) and remains completed. Sponsored by Novartis Pharmaceuticals, it has been updated 24 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
24 versions recorded-
Jan 2026 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2025 — Jan 2026 [monthly]
Active Not Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
Jul 2025 — Aug 2025 [monthly]
Active Not Recruiting
-
Feb 2025 — Jul 2025 [monthly]
Active Not Recruiting
▶ Show 19 earlier versions
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Apr 2024 — Jun 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2024 — Apr 2024 [monthly]
Recruiting
-
Jan 2024 — Feb 2024 [monthly]
Recruiting
-
Dec 2023 — Jan 2024 [monthly]
Recruiting
-
Nov 2023 — Dec 2023 [monthly]
Recruiting
-
Sep 2023 — Nov 2023 [monthly]
Recruiting
-
May 2023 — Sep 2023 [monthly]
Recruiting
-
Sep 2022 — May 2023 [monthly]
Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Recruiting
-
Jun 2021 — Jun 2022 [monthly]
Recruiting
-
May 2021 — Jun 2021 [monthly]
Recruiting
-
Apr 2021 — May 2021 [monthly]
Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2020 — Dec 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Novartis Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aschersleben, Germany , Bayreuth, Germany , Berlin, Germany , Bonn, Germany , Breisach, Germany , Chemnitz, Germany , Cologne, Germany , Dresden, Germany , Esslingen am Neckar, Germany , Frankfurt am Main, Germany and 25 more locations